EDITOR'S notebook

But victory won't come easy for Burton. Cenveo's board of directors recently instituted a proverbial "poison pill" to thwart that effort. Perhaps the irony, in the fashion of the wealth racked up by those Wall Street mavericks of the '80s, is that Burton will most likely win either way. Despite his failed attempts to oust the existing management at Creo and have himself declared CEO, the $16.50 per share cash price that Eastman Kodak eventually paid for Creo conceivably netted Burton Capital Management and Toronto hedge fund Goodwood more than $61⁄2 million in profits on their investment of just under $7 million. Not a bad ROI, especially considering they didn't prevail.